Global Coagulation Protein Disorders Market Size To Exceed USD 10 Billion By 2035|CAGR 7.25
Category: HealthcareGlobal Coagulation Protein Disorders Market Size To Exceed USD 10 Billion By 2035 | CAGR 7.25
According to a research report published by Spherical Insights & Consulting, The Global Coagulation Protein Disorders Market Size is Expected To Hold a significant share by 2035, at a CAGR of 7.25% during the forecast period 2025-2035.
Get more details on this report -
Browse 240 Market Data Tables And 45 Figures Spread Through 130 Pages and In-Depth TOC On the "Global Coagulation Protein Disorders Market Size, Share, and COVID-19 Impact Analysis, By Type (Haemophilia A, Haemophilia B, Von Willebrand Disease, and Others), By End-user (Hospitals, Specialty Clinics, Diagnostic Centers, and Blood Banks), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/coagulation-protein-disorders-market
The Coagulation Protein Disorders Market Size refers to the industry encompassing the diagnosis, treatment, and management of conditions caused by abnormalities in blood-clotting proteins, like haemophilia and Von Willebrand disease. Coagulation disorders are conditions affecting the body's control over blood clotting, which means the body forms too many or too few blood clots. Genetic testing is performed to identify the specific gene mutations responsible for the coagulation protein disorders. Factor replacement therapy, antifibrinolytic agents, and desmopressin are several effective treatment regimes that are increasingly used to manage bleeding risk and improve patients’ quality of life. The growing healthcare infrastructure and biotechnological innovation for effective and safer therapies are providing market opportunities. The increasing prevalence of bleeding disorders, biotechnology advancements, and emphasis on research and development activities are driving the market. On the contrary, the increased cost of recombinant therapies, as well as stringent regulations and uncertainty in reimbursement policies, are challenging the market growth.
The haemophilia A segment dominated the market with a major revenue share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the type, The Coagulation Protein Disorders Market Size is divided into haemophilia A, haemophilia B, Von Willebrand disease, and others. Among these, the haemophilia A segment dominated the market with a major revenue share in 2024 and is projected to grow at a substantial CAGR during the forecast period. An increasing demand for hemostatic agents like antifibrinolytic agents as adjunctive therapy for enhancing clot stability and minimizing bleeding is contributing to propel the market in the haemophilia A segment.
The hospitals segment accounted for the dominant share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the end user, the coagulation protein disorders market is divided into hospitals, specialty clinics, diagnostic centers, and blood banks. Among these, the hospitals segment accounted for the dominant share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Increasing advancements in medical technology are encouraging the development of enhanced diagnostic-capable solutions in hospitals. Collaboration between key players and hospitals aids in propelling the market growth.
North America is expected to hold the majority share of the global coagulation protein disorders market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global coagulation protein disorders market during the forecast period. The increased presence of strong healthcare infrastructure and technological advancements in treatment modalities is driving the market. Further, the growing prevalence of bleeding disorders, along with an increasing age-related conditions affecting blood clotting, is propelling market demand.
Asia Pacific is anticipated to grow at the fastest pace in the global coagulation protein disorders market during the forecast period. An increasing investment in developing diagnostic solutions for treating coagulation disorders significantly contributes to driving the coagulation protein disorders market. Further, increasing demand for early diagnosis and treatment with a rising prevalence of blood disorders is primarily responsible for promoting the market growth.
Major vendors in the global coagulation protein disorders market are Bioverativ, Takeda, Chugai Pharmaceutical, CSL, Bayer HealthCare, Pfizer, Novo Nordisk, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In May 2025, CRISPR Therapeutics, a biopharmaceutical company, and Sirius Therapeutics, a clinical-stage biotech company, announced a strategic partnership to develop and commercialize siRNA therapies. SRSD107 is a next-generation, long-acting siRNA designed to selectively inhibit Factor XI (FXI), a key driver of pathological thrombosis with minimal impact on normal hemostasis.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the coagulation protein disorders market based on the below-mentioned segments:
Global Coagulation Protein Disorders Market, By Type
- Haemophilia A
- Haemophilia B
- Von Willebrand Disease
- Others
Global Coagulation Protein Disorders Market, By End-User
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Blood Banks
Global Coagulation Protein Disorders Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?